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University, Tokyo, JapanABSTRACT Polyglutamine tract-binding protein-1 (PQBP-1) is a 265-residue nuclear protein that is involved in transcriptional
regulation. In addition to its role in the molecular pathology of the polyglutamine expansion diseases, mutations of the protein are
associated with X-linked mental retardation. PQBP-1 binds specifically to glutamine repeat sequences and proline-rich regions,
and interacts with RNA polymerase II and the spliceosomal protein U5-15kD. In this work, we obtained a biophysical character-
ization of this protein by employing complementary structural methods. PQBP-1 is shown to be a moderately compact but largely
disordered molecule with an elongated shape, having a Stokes radius of 3.7 nm and a maximum molecular dimension of 13 nm.
The protein is monomeric in solution, has residual b-structure, and is in a premolten globule state that is unaffected by natural
osmolytes. Using small-angle x-ray scattering data, we were able to generate a low-resolution, three-dimensional model of
PQBP-1.INTRODUCTIONPolyglutamine tract-binding protein-1 (PQBP-1) is a nuclear
protein that is expressed predominantly in the central
nervous system. It was initially isolated as a binding partner
of Brn-2, a brain-specific transcription factor that harbors
a glutamine repeat (polyQ) tract (1–3). Although the exact
cellular function of PQBP-1 has yet to be elucidated, its
temporal expression pattern suggests a role in neuron prolif-
eration and development (3). Studies of the PQBP-1 homo-
logs in mice, nematode, and fly revealed its involvement in
lipid storage, learning, and long-term memory processes (4).
At the molecular level, PQBP-1 has been shown to be
involved in transcription activity (2,5) and pre-mRNA
splicing (6).
PQBP-1 consists of the WW domain, the polar amino-
acid-rich domain (PRD), and the C-terminal domain (CTD;
Fig. 1 a). The WW domain (residues 48–81) plays a role in
transcription regulation, owing to its interaction with RNA
polymerase II and proline-rich motifs (6–8). The PRD
features five hepta-polar amino-acid-rich repeats spanning
residues 104–138, followed by an imperfect run of repeating
pairs of oppositely charged residues, aspartate-arginine or
glutamate-arginine, (DR/ER repeat) up to residue 163. This
region of high charge density mediates binding to polyQ
tracts (2). The CTD (residues 190–265) is highly conserved
among PQBP-1 homologs and interacts with the spliceoso-
mal protein U5-15kD (9), linking PQBP-1 to the RNA pro-
cessing machinery of the cell.Submitted October 14, 2011, and accepted for publication February 13,
2012.
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0006-3495/12/04/1608/9 $2.00The binding of PQBP-1 to polyQ tracts led researchers
to investigate the potential roles the protein plays in the
polyglutamine expansion diseases. These inherited neurode-
generative disorders are characterized by the abnormal
lengthening of an otherwise harmless glutamine repeat in
the respective disease proteins. The role of PQBP-1 has
been specifically addressed in the case of spinocerebellar
ataxia type-1. Like the disease protein Ataxin-1, PQBP-1
is expressed at high levels in affected regions of the brain,
and both proteins localize to the nucleus and deposit as
inclusions (10). The ternary complex of PQBP-1, Ataxin-1
with an expanded polyQ tract and RNA polymerase II,
was shown to cause cell death by synergistically repressing
transcription (10).
In recent years, investigators have identified 11 mutations
in the PQBP-1 gene, all of which result in X-linked mental
retardation (XLMR) (11–17). In syndromic types, typical
sufferers present mental retardation, microcephaly, lean-
ness, and mild short stature (17), collectively known as
Renpenning syndrome. Carrier females do not show remark-
able phenotypic affects (12), but the details are not yet
known. Five XLMR mutations have been located in the
PRD of PQBP-1 (12), the most frequently reported one
being p.Arg153SerfsX41 in the DR/ER repeat as a result
of mutation in a particularly unstable AG-rich region of
exon 4 (13,14,16,17); five other mutations are C-terminal
to the PRD. Eight of these 10 mutations are frame shifts
that result in PQBP-1 proteins with mutated and truncated
C-termini, thus affecting its interaction with the spliceoso-
mal protein U5-15kD. A missense mutation, Y65C, within
the WW domain of PQBP-1 causes Golabi-Ito-Hall
syndrome (11).doi: 10.1016/j.bpj.2012.02.047
ab
FIGURE 1 Primary sequence analysis of PQBP-1. (a) DISOPRED2
prediction of local disorder as a function of residue number. The dotted
line indicates a 5% false-positive threshold. The domain structure of
PQBP-1 is shown at the bottom. (b) Plot of net charge versus hydropathy
as a predictor of disorder, compared with a database of folded (gray
squares) and unfolded (open circles) proteins. The position of PQBP-1 is
shown as a black circle. The boundary condition is shown as a sloping
line having the equation hRi ¼ 2:785hHi  1:151, where hRi is the absolute
mean net charge and hHi is the mean scaled hydropathy (20).
Solution Model of PQBP-1 1609Given the particular medical significance of PQBP-1, we
sought to investigate its molecular structure. In a previous
study, PQBP-1 was established to be intrinsically unstruc-
tured, with a small folded WW domain (18). Spectroscopic
evidence suggests that the Y65C mutation disrupts the fold
of the isolated WW domain and reduces the domain’s
affinity for proline-rich ligands (8). Here we employed
small-angle x-ray scattering (SAXS) in combination with
other biophysical techniques to obtain a structural model
of full-length PQBP-1 in solution.MATERIALS AND METHODS
Primary sequence analysis
The primary sequence of PQBP-1 was analyzed with the use of
DISOPRED2 (19) to identify regions of disorder. The mean net
charge and hydropathy of PQBP-1 were calculated and plotted (20) with
the use of PONDR (21). The frequency of order- and disorder-promoting
residues was calculated based on the classification proposed by Dunker
et al. (22).Construction of expression plasmid
The cDNA encoding PQBP-1 was amplified from the plasmid GST-B83-
4/PCR (1,10) by polymerase chain reaction (PCR) with the following
primers:
50-GGGGACAAGTTTGTACAAAAAAGCAGGCTCCCTGGAAGTTC
TGTTCCAGGGGCCCATGCCGCTGCCCGTTGCG-30 and
50-GGGGACCACTTTGTACAAGAAAGCTGGGTTCAATCCTGCTG
CTTGGTTCG-30
The PCR product was subcloned into the Gateway donor vector
pDONR221 (Life Technologies, Grand Island, NJ) to generate the entry
clone, which was subsequently recombined with the destination vector
pHMGWA (23) to create the expression vector, pHMGW-PQBP1. This
plasmid encodes for PQBP-1 fused with an N-terminal hexahistidine and
maltose-binding protein (His6-MBP) tag, which is cleavable with PreSci-
ssion protease.Expression and purification
The fusion protein His6-MBP-PQBP-1 was overexpressed in Escherichia
coli strain Rosetta 2 DE3 (Merck, Darmstadt, Germany). The cells were
cultured at 37C to an absorbance at 600 nm of 0.6 when expression was
induced by addition of isopropyl-b-D-thiogalactopyranoside to 0.5 mM,
followed by growth at 18C for 16 h. Cells were pelleted and resuspended
in binding buffer (20 mM Na2HPO4 pH 7.4, 150 mM NaCl) with 40 mM
imidazole. The cleared lysate was loaded onto a HisTrap column (GE
Healthcare, Little Chalfont, UK), and purification was performed according
to the manufacturer’s instructions. The purified sample was dialyzed against
PreScission buffer (20 mM Tris-HCl pH 7.0, 150 mM NaCl, 1 mM DTT,
1 mM EDTA), and digested with PreScission protease at 4C overnight.
The digested samples were loaded onto a HisTrap column again, and
PQBP-1 was eluted with 150 mM imidazole. Finally, the proteins were
loaded onto a Superdex 75 column (GE Healthcare) and eluted in phos-
phate-buffered saline (PBS, pH 7.4). Their identity was confirmed by elec-
trospray ionization mass spectrometry.Size exclusion chromatography
We performed analytical gel filtration with a Superdex 75 16/60 column to
determine the molecular mass of PQBP-1 by comparing its elution volume
(Ve) with that of reference proteins. The void volume (V0) was determined
with Dextran blue. We determined the Stokes radius (RS) of PQBP-1 using
a linear calibration plot of [–log(Kav)]
1/2 against RS of the standards, where
the partition coefficient, Kav ¼ (Ve – V0) / (Vt – V0), with Vt being the total
volume of the column.Analytical ultracentrifugation
Sedimentation velocity experiments were performed on a Beckman Coulter
model XL-A analytical ultracentrifuge equipped with UV scanning optics.
PQBP-1 in PBS (380 mL) at concentrations of 0.83, 0.42, and 0.17 mg/mL
was loaded into 12 mm double-sector cells with quartz windows along with
a reference buffer (PBS). Experiments were performed with centrifugation
at 50,000 rpm at 20C, with 324 scans monitored at 280 nm collected
continuously.
Data from the first 160 scans were fitted to a continuous sedimentation
coefficient distribution c(s) via the program SEDFIT (24). This model
employs direct boundary modeling with a distribution of Lamm equation
solutions to derive a differential s distribution, with diffusion effects (24).
The buffer density (r¼ 1.005235 g/mL), buffer viscosity (h¼ 1.018906 cP),
and partial specific volume of the sample (v¼ 0.711319mL/g) at 20Cwere
computed with the program SEDNTERP (25). Regularization of the c(s)
distribution was based on the simplex algorithm by maximum entropyBiophysical Journal 102(7) 1608–1616
1610 Rees et al.method with a confidence interval of P¼ 0.95, with the frictional coefficient
ratio (f/f0) as a parameter. Model fitting was repeated until the lowest root-
mean-square deviation between the data and the calculated curves was
achieved. The sedimentation coefficients of the peaks were corrected to
s20,w, the standard s-values in water at 20
C. The values of s20,w and f/f0
were plotted against sample concentration, and the corresponding values at
infinite dilution, s020;w and f/f0
0, were obtained by extrapolation. The molar
mass M corresponding to each peak in the c(s) distribution was calculated
with the equation M ¼ (sRT) / [D (1– v r)], where T is the temperature, R
is the gas constant, D is the diffusion coefficient of the sedimenting species
characterized by the sedimentation coefficient s, and r and v are defined as
above. The Stokes radius is calculated as implemented in the calculator
tool of SEDFIT.NMR
The 1H NMR spectrum of PQBP-1 in native buffer (20 mM Tris-HCl
pH 7.0, 150 mM NaCl, 1 mM DTT) was acquired at a concentration of
0.2–0.5 mM (0.06–0.16 mg/mL) on a Varian 600 MHz spectrometer at
25C. The water signal was suppressed by the WATERGATE pulse
sequence (26). The final spectrum was acquired by summing 128 scans.Circular dichroism
Simultaneous UV and circular dichroism (CD) spectra of PQBP-1 at
0.35 mg/mL in CD buffer (20 mM Tris-HCl pH 7.0, 150 mM NaF) were
measured on a Chirascan-Plus spectrometer (Applied Photophysics Ltd.,
Leatherhead, UK). Spectral data were collected from 260–180 nm in a
0.01 mm rectangular spacer cell at 20C. Measurements were recorded
with a 1 nm step size, a 1 s acquisition time-per-point, and a spectral band-
width of 1–2 nm. For variable temperature measurements, the CD spectra of
0.17 mg/mL PQBP-1 were recorded in a 0.5 mm pathlength cell. The
sample was heated from 6C to 94C and then cooled to 20C at a rate
of 1C per minute with a 2C step size. A 0.8 s time-per-point acquisition
time and 1 nm step-size were employed in the 260–190 nm region with
a 2 nm spectral bandwidth.
We calculated the relative frequency of secondary structural elements of
PQBP-1 via the DichroWeb server (27) using the CDSSTR algorithm (28)
and reference set 3, for data from 185 –240 nm. Deconvolution yielded
a best solution and many other valid solutions, as assessed by the normal-
ized standard deviation (NRMSD). The top 20 solutions were analyzed for
the general trend in secondary structure composition.Florescence spectroscopy
1-Anilino-8-napthalene-sulfonate (ANS; Sigma, St. Louis,MO) is a fluores-
cence probe that is commonly used to detect the molten globule state of
proteins (29). The fluorescence spectra of 20 mM ANS was monitored at
20C upon incubation with 20 mM (0.62 mg/mL) PQBP-1 in PBS, PBS
with 1 M L-proline, PBS with 1 M trimethylamine N-oxide (TMAO), and
PBS with 8 M urea in a FluoroMax-4 spectrofluorometer (Horiba Scientific,
Edison, NJ). The fluorescence spectra of ANS in the same buffers without
protein were also recorded. An excitation wavelength of 370 nm was used,
and the emission spectra were recorded from 400–600 nm. All samples
were incubated in the cell compartment at 20C for>5 min before measure-
ments were taken.SAXS experiments and data processing
SAXS experiments were performed at the European Molecular Biology
Laboratory X33 beamline of the Deutsches Elektronen-Synchrotron
(Hamburg, Germany) using a robotic sample changer. The scattering by
PQBP-1 in native buffer was measured at five concentrations rangingBiophysical Journal 102(7) 1608–1616from 1 to 13 mg/mL on a Pilatus 1M detector (Dectris, Baden, Switzerland).
The sample–detector distance was 2.7 m covering the momentum transfer
range 0.07 < q < 6.24 nm1, with q ¼ (4p/l) sinq, where 2q is the scat-
tering angle, and wavelength l ¼ 1.5 A˚. A standard acquisition time of
2 min was used for all samples, and divided into eight 15-s frames to assess
and correct for radiation damage.
We processed the data using standard procedures for ATSAS programs
(30). We evaluated the forward scattering I(0) and the radius of gyration
Rg using the Guinier approximation (31). We also computed these parame-
ters from the entire scattering patterns using the indirect transform package
GNOM (32), which also provided the pair distribution function of the
particle p(r) and the maximum size Dmax. We evaluated the molecular
mass of the sample by comparing the forward scattering I(0) with that
from a reference solution of bovine serum albumin.Structural modeling of the SAXS data
A Kratky plot was employed to qualitatively assess the overall conforma-
tional state of PQBP-1 (33). To obtain quantitative estimates of the
degree of the dynamics and conformational heterogeneity, we
analyzed the SAXS data using an ensemble optimization method (EOM)
(34). First, we used the program RANCH to generate a pool of 10,000
random structures, and calculated the scattering curve of each structure
with the use of CRYSOL (35). Initial pools were generated with either
native-like (more compact) or completely random chains. In each case,
two models, one with and one without a structured WW domain (built
with MODELLER as described previously (6)), were generated. Each of
these four initial pools was subjected to a genetic algorithm (GAJOE) for
selection of subsets of ~20 protein structures such that the discrepancy
(the c2 value) between the average scattering of the ensemble model and
the experimental data was minimized. For each pool, 12 independent
EOM runs were performed, and the obtained subsets were analyzed to yield
the Rg and Dmax.
The low-resolution ab initio shape of PQBP-1 was reconstructed with
the use of DAMMIF (36). Compact models of interconnected beads
were used to represent the molecule, and simulated annealing was
employed to minimize the discrepancy between the experimental and calcu-
lated data. Ten DAMMIF models were generated and analyzed using
DAMAVER (37), which characterizes the similarity between the individual
ab initio models by the normalized spatial discrepancy (NSD) (38).
The most representative model (with the lowest average NSD) was visual-
ized in the graphics program QuteMol (39) with the sphere radius set to
2.7 A˚.Availability of materials
The coordinates of the average bead model of PQBP-1 and the color version
of all figures can be obtained from the corresponding authors.RESULTS
PQBP-1 is predicted to be disordered
The primary sequence of PQBP-1 was analyzed to predict
disorder in the protein at both local and global scales. Its
amino-acid composition shows a significantly higher pro-
portion of disorder-promoting residues (59.6%) and a lower
proportion of order-promoting residues (17%) relative to the
typical composition for globular proteins (47.4% and
36.2%, respectively). The DISOPRED2 server predicts
order at the region corresponding to the WW domain
(Fig. 1 a). A stretch of ~100 residues then follows,
Solution Model of PQBP-1 1611encompassing the PRD, which is predicted with confidence
to be disordered. The CTD is predicted to be disordered, but
with lower confidence. The prediction mirrors a previous
disorder prediction of PQBP-1 made with PONDR (18).
Overall, PQBP-1 has a low net charge and low overall
hydropathy, and falls in the disordered region of the
charge/hydropathy plot (Fig. 1 b).PQBP-1 is monomeric and nonglobular
During size exclusion chromatography (SEC), PQBP-1
eluted from the column in two peaks (a small one followed
by a major peak; Fig. 2 a). The two peaks correspond
to apparent molecular masses of 89.7 (52.3) kDa and
63.3 (51.5) kDa, and Stokes radii of 4.36 (50.63) nm
and 3.50 (50.55) nm, respectively. The first peak corre-
sponds to an apparent molecular mass exceeding the
resolving power of the S75 column (>75 kDa) and contains
aggregated proteins. The major peak has an elution volume
that corresponds to two times the molecular mass of
PQBP-1 (30.6 kDa), suggesting that the protein is dimeric
if it adopts a compact, globular conformation. However, it
is well established that elongated or unfolded proteins elute
at a volume corresponding to a higher apparent molecular
mass (40).
Analytical ultracentrifugation (AUC) was carried out to
clarify the oligomeric state of PQBP-1. Sedimentation
velocity studies showed that PQBP-1 species were homoge-
neous in solution, with a single species observed for each
preparation (Fig. 2 b). Over the concentration range tested,
PQBP-1 showed no sign of self-interaction. A distribution
analysis revealed a single peak at s020;w ¼ 2.13 (50.02) S,
which accounts for >95% of the sedimenting materials
and corresponds to a molar mass of 31.0 (50.5) kDa, in ex-
cellent agreement with the monomeric molecular mass. The
frictional coefficient ratio (f/f0) has a value of 1.74 (50.09),
which suggests that PQBP-1 is highly elongated. The Stokes
radius of PQBP-1 calculated from these experiments is
3.67 (50.02) nm.a bPQPB-1 is disordered but retains residual
structure
We recorded a one-dimensional (1D) 1H NMR spectrum to
assess the overall solution state of PQBP-1 (Fig. S1 in the
Supporting Material). The chemical shift range covered by
the spectrum is narrow, with the highest shifts visible around
8.5 ppm, and the lowest at ~0.5 ppm. The resonances of the
amide and aromatic protons, expected to be at the left of
the central water signal (4.7 ppm), are all clustered within
~2 ppm (6.5–8.5 ppm). This lack of chemical shift disper-
sion is typical of unfolded and/or highly flexible proteins.
However, the presence of a peak at ~0.2 ppm and of two
very faint resonances at 10.4 and 10.9 ppm is in agreement
with locally folded regions, such as the WW domain. These
resonances are likely to account for at least two of the four
tryptophan indole protons. One would expect to see more
dispersed peaks in the backbone region due to the folded
WW domain. However, the resonances of the more-substan-
tial unfolded regions can dominate and determine the
dynamic range of the spectrum. Folded and unfolded
regions are also expected to have different degrees of flexi-
bility and exchange regime, thus resulting in resonances
with very different linewidths.
The CD spectrum of PQBP-1 (Fig. 3 a) is typical of a
protein or peptide without regular conformation: it lacks
spectral features or any positive signals in the far-UV range,
and has a characteristic negative maximum at 200 nm
(41,42). The absence of a positive CD signal below
200 nm indicates that there is very little or no helical struc-
ture. The spectrum was deconvoluted satisfactorily, with the
back-calculated spectrum closely resembling the experi-
mental data, as reflected in a low NRMSD value of 0.017
(Fig. 3 a). From the top 20 solutions (data not shown), the
spectrum is found to consist of a significant amount of
b-strand structure (~20–50%) and turns (~15–40%), but
little helical content (~5–10%). The remaining regions of
the protein (~25–55%) are irregular structures. The variable
temperature CD results are also typical of a disorderedFIGURE 2 Hydrodynamic properties of
PQBP-1. (a) SEC elution profile of PQBP-1 with
the corresponding elution volume of molecular
mass markers indicated: D, dextran; B, bovine
serum albumin (66 kDa, RS ¼ 3.64 nm); CA,
carbonic anhydrase (29 kDa, RS ¼ 2.22 nm); C,
cytochrome C (12 kDa, RS ¼ 1.69 nm). The small
peak at an elution volume of ~50 ml corresponds
to aggregated samples. The apparent molecular
mass of the major peak was determined from a cali-
bration plot made with the standard proteins. (b)
Velocity sedimentation AUC results analyzed with
SEDFITare presented as the concentration distribu-
tion c(s) of sedimentation species at three sample
concentrations. The inset shows the sedimentation
coefficients corresponding to the major peak in
c(s) plotted against their respective sample concen-
trations to obtain the s020;w value at infinite dilution.
Biophysical Journal 102(7) 1608–1616
ab
FIGURE 3 CD of PQBP-1. (a) The far-UV CD spectrum (molar ellip-
ticity) is shown as a gray line. The dashed black line (185–240 nm) is the
back-calculated spectrum after deconvolution by the CDSSTR algorithm.
(b) Temperature dependence of the CD spectra of PQBP-1. The sample
was heated from 6C (lightest gray) to 90C (dark gray), and then cooled
to 20C (*, black). The inset shows the CD at 225 nm as a function of
temperature.
1612 Rees et al.protein, with a broad melting profile (Fig. 3 b). The CD
spectra of PQBP-1 recorded at high temperatures differ
significantly from those recorded at 20C, indicating that
the protein undergoes reversible denaturation, with a melting
temperature (Tm) of ~34
C (Fig. 3 b, inset). Native confor-
mations are restored when the protein is subsequently
cooled.PBQB-1 is in the premolten globule state
PQBP-1 is natively disordered yet possesses a substantial
amount of secondary structure contents, which fits a descrip-
tion of the molten globule, an intermediate state between
the unfolded and folded states of proteins. Incubation of
PQBP-1 with ANS in the native condition (PBS) results in
a blue shift of the fluorescence spectral peak from 510 nm
to 475 nm accompanied by a threefold increase in quantum
yield (Fig. 4 a). These effects are characteristic of ANS
binding to a species adopting a premolten or molten-globuleBiophysical Journal 102(7) 1608–1616conformation. The relatively small increase in quantum
yield suggested that ANS binding to PQBP-1 is not hydro-
phobic but instead is electrostatic in nature (43). Next, we
tested whether the natural osmolytes TMAO and proline
could promote a more folded conformation of PQBP-1,
because it is known that these small molecules can induce
structure in certain partially folded or denatured proteins
(44,45). We found that addition of TMAO or proline did
not alter the blue shift or intensity increase effects upon
PQBP-1 binding to ANS (Fig. 4, c and d). In 8 M urea,
the ANS fluorescence spectrum collected in the presence
of PQBP-1 showed a small increase in peak height (at
515–520 nm) but no blue shift, suggesting that PQBP-1 is
totally unfolded in denaturing conditions (Fig. 4 b).
We then calculated the theoretical Stokes radii of mono-
meric PQBP-1 in various known conformations (Table 1).
There is a linear dependency between log(RS) and the loga-
rithm of molecular mass for proteins in different states (46).
The RS of PQBP-1 obtained from gel filtration (3.50 nm)
agreeswell with that determined from sedimentationvelocity
experiments (3.67 nm), and that predicted for a natively
disordered premolten globule protein (3.70 5 0.41 nm). It
also falls into the broad range (3.53 5 2.09 nm) covered
by the premolten globule state of a folded protein, and
marginally into the natively unstructured randomcoil confor-
mations. The calculatedRS for other conformational states do
not agree with the experimentally determined value. This
analysis strongly supports the notion that PQBP-1 adopts
a premolten globule conformation.Solution model of PQBP-1
We employed SAXS to study the overall shape and confor-
mational flexibility of PQBP-1 in solution. The processed
scattering pattern of PQBP-1 (Fig. 5 a) yields an Rg of
3.8 (50.2) nm, with a molecular mass of 30 (53) kDa,
suggesting that the protein remains monomeric in solution.
The ratio of the Rg to the hydrodynamics radius (determined
by AUC and SEC) is an indicator of the compactness of
a protein. PQBP-1 has an Rg/RS ratio of 1.0, which is inter-
mediate between the value of a spherical species (0.8) and
that of an unstructured random coil (1.5) (47). The Kratky
plot (Fig. 5 b, inset) is not indicative of a compact, globular
protein (which is typically bell shaped) or a fully unfolded
protein, which would show a plateau or upward slope at
higher scattering angles. Instead, this plot shows a peak at
approximately q¼ 1 nm1 followed by a shallow downward
slope, suggesting that PQBP-1 is partially unfolded. The
p(r) function of PQBP-1 has an asymmetric shape (Fig. 5 c),
with its maximum at low r followed by a long tail. This is
again consistent with an extended, perhaps partially
unfolded molecule with the maximum dimension (Dmax)
equal to 13 nm.
Because the Kratky plot, p(r) function, and other biophys-
ical analyses of PQBP-1 all indicated that the protein is
a b
dc
FIGURE 4 ANS fluorescence spectroscopy of
PQBP-1. Each set of measurements consists of
two spectra, one with ANS and buffer only (dashed
line) and the other with ANS, buffer, and PQBP-1
(solid line). (a and b) Spectra in the (a) native
condition (PBS, black lines) and (b) denaturing
condition (8 M urea, dark gray lines). (c and d)
Spectra with osmolytes in PBS: with (c) 1 M
TMAO (light gray lines) and (d) with 1 M proline
(gray lines). The peak of each spectrum is identi-
fied with a vertical line, and the blue shift caused
by PQBP-1 is indicated by an arrow. Spectra in
the native condition (black lines) are shown for
comparison in all panels.
Solution Model of PQBP-1 1613partially unfolded, we employed an ensemble method
(EOM) to quantitatively assess its flexibility. The best
EOM solution was obtained from the most compact initial
pool that employs the fixed WW domain and the native-
like chains, with a c2 value of 0.86 (Fig. 5 a). A value
of <1 indicates a good agreement between the calculated
scattering of the ensemble model and the experimental scat-
tering (35). In contrast, the data generated from the average
over the random conformations (i.e., the initial pool for the
EOM ensemble) display significant systematic deviations
from the data (Fig. 5 a).
The EOM-selected ensemble shows a major fraction of
the population (Fig. 5 d) displays Rg values of ~3.5 nm,
which is much smaller than the average Rg of the random
population of 4.2 nm. This suggests that the optimizedTABLE 1 Theoretical Stokes radii for monomeric PQBP-1
Conformation model RS, nm
Globular states
Folded 2.495 0.18
Molten globule 2.785 0.85
Premolten globule 3.535 2.09
Unfolded, urea/GdnHCl 4.875 2.7 / 5.155 5.4
Natively unstructured states
Premolten globule 3.705 0.41
Unfolded 4.575 0.81
Values were calculated with a molecular mass of 30,472 Da in different
conformation models.ensemble was even more compact and more enriched with
the structures than the random pool (Fig. 5, d and e). There
is also a peak with Rg values well over 6 nm. Together, these
findings indicate that the protein is compact but explores
a conformation space that includes rather extended
dimensions.
Because the results from the CD, NMR, and EOM anal-
yses provided evidence that PQBP-1 contains some struc-
ture and is not fully unfolded, we performed ab initio
modeling to visualize its average solution conformation.
Ten independent models were generated by DAMMIF, and
all fit the experimental data well with c2-values of ~0.9
(Fig. 5 b). The models align with an average NSD value
of 0.78, indicating a stable shape reconstruction (48). For
comparison, we also computed the scattering curves from
the best-fit ellipsoid and a sphere model, and the results
show that the data cannot be reconciled with a simple shape
model (Fig. S2). The most representative DAMMIF model,
presented in Fig. 5 f, has an extended conformation, with
both ends protruding from a bulkier core. The longest
molecular dimension of the model is 13 nm, in agreement
with the Dmax obtained from the p(r) function.DISCUSSION
From this combined biophysical study, a molecular view of
PQBP-1 is emerging. The protein is monomeric but its
shape deviates greatly from globularity. The hydrodynamicBiophysical Journal 102(7) 1608–1616
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FIGURE 5 SAXS analysis of PQBP-1. The experimental x-ray scattering data are shown as open circles, along with the calculated scattering curves (black)
from (a) EOM analysis and (b) DAMMIF reconstruction. The calculated scattering curve of the initial randomized ensemble before EOM is shown in gray in
panel a. The Kratky plot is shown as an inset. (c) The p(r) distribution of PQBP-1. (d and e) Results of the EOM study showing the distribution of the Rg (d)
and Dmax (e). The distributions of the random pool are shown in gray, and those of the selected ensemble are in black. (f) Two views of the ab initio bead
model of PQBP-1 calculated using DAMMIF. The model shown is the most representative of 10 structures calculated. a.u., arbitrary unit.
1614 Rees et al.behavior of PQBP-1 is intermediate between that of a fully
folded protein and that of a completely random coil. It
contains some local structure and is moderately compact
but lacks a folded core. The ab initio molecular shape recon-
structed from the SAXS data results in an elongated
molecule.
Our results on the residual structure agree well with
previous findings (18). Although the NMR spectrum is too
broad to allow appreciation of details, due to the molecular
mass of the protein, it does reveal some chemical shiftBiophysical Journal 102(7) 1608–1616dispersion, indicating the presence of some structure. The
far-UV CD spectrum also agrees with that described in
the earlier study (18) and is typical of a mostly unstructured
peptide. Here, we extended that study significantly by
including CD data beyond 200 nm, which is important in
the deconvolution of the spectrum. We interpreted the CD
results with caution given that current methods of CD spec-
tral analysis are not ideally adaptable to proteins with a large
degree of disorder, because the reference databases consist
mainly of globular folded proteins (27). Nevertheless, the
Solution Model of PQBP-1 1615top 20 deconvolution solutions show a clear consensus
regarding the range of secondary structures present, reflect-
ing the fact that PQBP-1 adopts dynamic and transient
conformations in the solution state. The variable-tempera-
ture CD experiment shows that PQBP-1 follows a noncoop-
erative melting between an extended and an unfolded state.
With a Tm of ~34
C, any order is likely to be relatively tran-
sient at physiological temperatures.
The experiments reported here demonstrate conclusively
that PQBP-1 is best described as being in the premolten
globule state, which was originally investigated in the
context of protein folding, i.e., the intermediate state en route
to becoming a globular protein (49). The characteristics of
the molten globule are that it has similar secondary structural
elements with the native folded state, but the tertiary interac-
tions are absent; the protein remains globular but loosely
packed. The premolten globule is a state in which only
~50%of native secondary structures are present and the over-
all conformation is extended and nonglobular (33). The
molten globule and premolten globule states can be detected
when natively globular proteins are subjected to various
denaturing conditions. The propensity for proteins to be
unstructured under physiological conditions was later appre-
ciated by Wright and Dyson (50). In particular, this has been
observed in the eukaryotic proteome: it was calculated that
whereas 2–4% of prokaryotic proteins contain disordered
regions, 33% of eukaryotic proteins contain sizable regions
(>30 residues long) of native disorder (19).
The persistence of intrinsically disordered states in the
proteomes of organisms demonstrates the crucial role that
conformations play in protein function. Proteins containing
disorder are overrepresented in certain functional classes
(19), including transcriptional regulation and development
processes in which PQBP-1 is involved. Furthermore, these
proteins are disproportionately found in the nucleus,
including in transcription factor complexes (19), as is
PQBP-1 (10). A protein that adopts a flexible, adaptable
conformation can bind to multiple different targets. The
interactions tend to be highly specific but have a low affinity
(51). Of interest, PQBP-1 was observed to bind to nickel
resin during preparative purification of the protein, presum-
ably via its highly charged disordered PRD (Fig. 1 c). This is
the region that binds to polyQ tracts, which is also disor-
dered, as revealed in a number of experiments (52–54). It
is conceivable that its conformational variability offers
PQBP-1 the advantage of adaptive binding to disordered
targets, and links to its specific role in the pathogenesis of
polyQ diseases. Although some disordered regions of pro-
teins can form structure on binding to targets, many proteins
do not exhibit this behavior (55). The CTD of PQBP-1 has
been shown to remain disordered upon binding to U5-15kD
(56), and here we have shown that PQBP-1 cannot be
promoted into a state of higher folding by natural osmolytes.
However, we cannot rule out the possibility that other
binding partners can induce structure formation.In this work, we acquired knowledge about the unique
molecular properties of PQBP-1. Our hydrodynamic and
biophysical characterizations of this protein, along with
the low-resolution solution model, will pave the way for
studying the molecular interactions of PQBP-1, which
have many medical implications.SUPPORTING MATERIAL
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